CARB-X awards LimmaTech US$6.5 million to advance clinical development of LBT-SA7 “We are grateful for the significant support from CARB-X, which is not only instrumental in accelerating the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback